Biosino Bio-Technology and Science (HKSE:08247) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08247 Biosino Bio-Technology and Science Inc HKSE:08247
37 GF Score
Price HK$3.17
GF Value HK$0.44
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biosino Bio-Technology and Science FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:08247
37GF Score
Biosino Bio-Technology and Science Inc HKSE:08247
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biosino Bio-Technology and Science (HKSE:08247) Overvalued in 2026?

Based on GuruFocus' analysis, Biosino Bio-Technology and Science stock appears to be overvalued. The current stock price of HK$3.17 is trading 619.3% above its estimated GF Value™ of HK$0.44. GuruFocus considers Biosino Bio-Technology and Science to be Significantly Overvalued.

Key valuation signals for HKSE:08247:

  • FFO:
  • GF Value™: HK$0.44 vs. price of HK$3.17 (619.3% above fair value)
  • GF Score™: 37/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biosino Bio-Technology and Science Business Description

Address No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of IVD reagent products. The company operates in a single segment, the in-vitro diagnostic products segment, which manufactures, sells, and distributes a variety of mono/double diagnostic products. Geographically, it generates the majority of the revenue from Mainland China.
37GF Score

Get the complete analysis for HKSE:08247

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.17
Price
HK$0.44
GF Value